The synthesis of several (3-noradamantyl)amines, [(3-noradamantyl)methyl]amines, (3,7-dimethyl-1-bisnoradamantyl)amines, and [(3,7-dimethyl-1-bisnoradamantyl)methyl]amines is reported. They were evaluated against a wide range of viruses and one of them inhibited the cytopathicity of influenza A virus at a concentration similar to that of amantadine. Several of the new polycyclic amines show an interesting activity as NMDA receptor antagonists. A rimantadine analogue displayed significant trypanocidal activity. Moreover, to further characterize the pharmacology of these compounds, their effects on dopamine uptake were also assessed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125889 | PMC |
| http://dx.doi.org/10.1016/j.bmc.2008.10.028 | DOI Listing |
Publication Analysis
Top Keywords
synthesis pharmacological
4
pharmacological evaluation
4
evaluation ring-contracted
4
ring-contracted amantadine
4
amantadine analogs
4
analogs synthesis
4
synthesis 3-noradamantylamines
4
3-noradamantylamines [3-noradamantylmethyl]amines
4
[3-noradamantylmethyl]amines 37-dimethyl-1-bisnoradamantylamines
4
37-dimethyl-1-bisnoradamantylamines [37-dimethyl-1-bisnoradamantylmethyl]amines
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!